Analytical Data
-
Gene name
FNDC3B
- Application
-
Alternative Names
(Factor for adipocyte differentiation 104)(HCV NS5A-binding protein 37)
-
Species
Human
-
Source
Yeast
-
Tag
C- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q53EP0
-
Expression Region
278-570aa
-
Molecular Weight
34.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FNDC3B (fibronectin type III domain-containing protein 3B) is a protein that has gained attention in recent years due to its potential roles in various biological processes, including cellular signaling, development, and disease progression. The interest in FNDC3B is primarily sparked by its association with metabolic regulation and its involvement in the pathophysiology of several conditions, such as obesity and insulin resistance. As an emerging focus in biomedical research, FNDC3B is being explored for its function in adipogenesis and energy metabolism, where it may influence the differentiation of adipocytes and modulate lipid metabolism. Additionally, studies suggest that FNDC3B may play a role in the modulation of immune responses and inflammation, further broadening its relevance in chronic diseases. Given the increasing prevalence of metabolic disorders globally, understanding the molecular mechanisms underlying FNDC3B's function could unveil new therapeutic targets. Consequently, the recombination and characterization of FNDC3B protein not only contribute to elucidating its biological roles but also offer insights into its potential applications in clinical settings, particularly in the development of novel interventions for metabolic syndromes and other related diseases.
